SEARCH

Search Details

Fujiyoshi Sunao

Hokkaido University Hospital Surgery Gastroenterological SurgeryⅠSpecially Appointed Assistant Professor

Researcher basic information

■ Degree
  • Ph.D., Hokkaido University, Jun. 2020
■ URL
researchmap URLホームページURL■ Various IDs
Researcher number
  • 00892530
J-Global ID■ Research Keywords and Fields
Research Field
  • Life Science, General surgery and pediatric surgery, 移植外科

Research activity information

■ Awards
  • Jun. 2025, Japanese Society of Hepato-Biliary-Pancreatic Surgery, Japanese Society of Hepato-Biliary-Pancreatic Surgery Outstanding Original Article Award in 2024
    SGLT2 is upregulated to acquire cisplatin resistance and SGLT2 inhibition reduces cisplatin resistance in hepatoblastoma
    Fujiyoshi Sunao
  • Jul. 2023, The Japanese society of gastroenterological surgery, Outstanding Paper Award
    Curative Liver Resection in a Case of Cecum Cancer Liver Metastasis after Coronavirus Disease-19 Following Percutaneous Transhepatic Portal Vein Embolization
    Fujiyoshi Sunao
■ Papers
  • Survival benefit of lymph node dissection and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma.
    Kyohei Yugawa; Shinji Itoh; Takuma Izumi; Takeo Toshima; Takashi Motomura; Sunao Fujiyoshi; Norifumi Iseda; Yuriko Tsutsui; Tomoharu Yoshizumi
    Surgery today, 56, 4, 525, 532, Apr. 2026, [Domestic magazines]
    English, Scientific journal, PURPOSE: Lymph node metastasis (LNM) is strongly associated with a poor survival in patients with intrahepatic cholangiocarcinoma (ICC). However, the indications for lymph node dissection (LND) are controversial. This study assessed the accuracy of preoperative imaging for detecting LNM. METHODS: Eighty-nine patients who underwent curative resection for ICC between 2001 and 2022 were enrolled and analyzed retrospectively. Lymph node status was evaluated preoperatively using contrast-enhanced computed tomography (CT) and positron emission tomography (PET)/CT. Patients were grouped according to their LND status (LND or no LND). Patients in the LND group were further grouped according to pathological LNM status (pN+, LNM-positive; and pN0, LNM-negative). RESULTS: Adequate LND was performed in 44 (49.4%) patients, among whom LNM was diagnosed in 17 (38.6%). The 3-year overall survival rates in patients with LND/pN+, LND/pN0, and no LND were 16.2%, 70.0%, and 70.7%, respectively. The corresponding 3-year recurrence-free survival rates were 11.8, 52.6, and 42.6%, respectively. A lymph node diameter > 8 mm on preoperative CT was an independent predictor of LNM. The maximum standardized uptake value (SUVmax) on PET/CT was significantly associated with LNM. CONCLUSION: Lymph node diameter and SUVmax predicted LNM in patients with resectable ICC. A preoperative lymph node evaluation can ensure optimal treatment outcomes.
  • Risks of Early Graft Loss in Living Donor Liver Transplantation for Patients With a Low Model for End-Stage Liver Disease Score: Is It Truly Safe?
    Yuki Nakayama; Takeo Toshima; Shinji Itoh; Takashi Motomura; Kyohei Yugawa; Sunao Fujiyoshi; Yuriko Tsutsui; Tomoharu Yoshizumi
    Transplantation proceedings, 58, 1, 169, 176, 2026, [International Magazine]
    English, Scientific journal, BACKGROUND: Living donor liver transplantation is the definitive treatment for decompensated cirrhosis. While the prognosis for high Model for End-Stage Liver Disease (MELD) patients is well-studied, risk factors in low MELD patients remain unclear. This study aimed to identify prognostic risk factors for low MELD cases. METHODS: We analyzed 838 adult living donor liver transplantation patients from September 1998 to April 2024 and divided them into low MELD (≤15) and high MELD (>15) groups. The low MELD group was further categorized into early and non-early graft loss subgroups. The risk factors for recipient survival were analyzed. RESULTS: Of the 838 patients, 408 (48.7%) were in the low MELD group, and 430 (51.3%) were in the high MELD group. The survival rates were significantly higher in the low MELD group than in the high MELD group. In the low MELD group, 5.1% (21 patients) experienced early graft loss, and 94.9% (387 patients) were classified as non-early graft loss. Independent risk factors for early graft loss included donor body mass index ≥25 kg/m2, absence of simultaneous splenectomy, and postoperative complications. One year survival rates were significantly lower in patients with more risk factors. CONCLUSION: Donor body mass index, absence of simultaneous splenectomy, and postoperative complications were identified as independent risk factors for poor prognosis in living donor liver transplantation patients with low MELD. Surgeons must focus on performing meticulous surgeries to minimize the risk of complications.
  • Prognostic significance of Albumin-Bilirubin score changes in patients treated with systemic therapy for recurrent hepatocellular carcinoma after liver resection.
    Yoh Asahi; Tatsuhiko Kakisaka; Tatsuya Orimo; Shingo Shimada; Akihisa Nagatsu; Takeshi Aiyama; Sunao Fujiyoshi; Yuzuru Sakamoto; Yuki Fujii; Yuichi Yoshida; Shunsuke Shichi; Ken Imaizumi; Akinobu Taketomi
    Surgery today, 24 Dec. 2025, [Domestic magazines]
    English, Scientific journal, PURPOSE: To clarify the characteristics of patients who received systemic therapy for recurrent hepatocellular carcinoma after liver resection and evaluate the associated prognostic factors. METHODS: We retrospectively analyzed data from 177 hepatocellular carcinoma patients with recurrence after liver resection; 79 received tyrosine kinase inhibitors or immune checkpoint inhibitors. Prognostic factors were analyzed in the patients who received systemic therapy. RESULTS: The median survival time after the initiation of systemic therapy was 23.3 months among the patients who received such therapy. These patients had more advanced disease at recurrence than those who did not receive systemic therapy. In the systemic therapy group, a deterioration of liver function relative to the preoperative status, expressed as the change in the albumin-bilirubin score (≥ 0.469 vs. <0.469), was independently associated with a poorer survival (9.5 vs. 25.2 months, respectively; P = 0.022). Receiving multiple regimens was associated with a longer survival than receiving a single regimen (36.6 vs. 17.7 months, respectively; P = 0.023). Four patients (5.1%) achieved complete remission, two with systemic therapy alone and two after conversion therapy; all achieved a long-term overall survival. CONCLUSIONS: A preserved liver function and multiple systemic therapy regimens are favorable prognostic factors. Achieving complete remission results in an improved long-term survival.
  • [A Case of Intrahepatic Cholangiocarcinoma Treated with Extended Right Hepatectomy with Partial Resection of the Inferior Vena Cava Following Laparoscopic Portal Vein Ligation].
    Takeshi Aiyama; Tatsuhiko Kakisaka; Yoichi Yamamoto; Shunsuke Shichi; Yuki Fujii; Sunao Fujiyoshi; Akihisa Nagatsu; Norio Kawamura; Masaaki Watanabe; Ryoichi Goto; Akinobu Taketomi
    Gan to kagaku ryoho. Cancer & chemotherapy, 52, 13, 1420, 1422, Dec. 2025, [Domestic magazines]
    Japanese, Scientific journal, INTRODUCTION: Portal vein embolization(PVE)is a preoperative procedure that requires contrast media, making it contraindicated in patients with a history of contrast-induced anaphylaxis. We report a case of intrahepatic cholangiocarcinoma (ICC)in which laparoscopic right portal vein ligation(PVL)was performed as an alternative to PVE due to this contraindication. CASE: A 60-year-old woman was found to have a liver tumor during a health checkup. Further evaluation led to a diagnosis of ICC. The tumor was in close contact with the right and middle hepatic veins and the inferior vena cava(IVC) and showed enlarged hilar and para-aortic lymph nodes(#16b1). Surgery was initially deemed unfeasible at another hospital, and systemic chemotherapy(GEM+CDDP+durvalumab)was initiated, maintaining stable disease for approximately 1 year. She was referred for potential conversion surgery. Although PVE was indicated, it was contraindicated due to a history of contrast anaphylaxis. Therefore, laparoscopic right PVL was performed instead. On postoperative day 26, extended right hepatectomy with partial IVC resection, cholecystectomy, and lymphadenectomy(including #16b1 int & lat)was performed. Aside from autosensitization dermatitis, her postoperative course was uneventful, and she was discharged on day 17. CONCLUSION: Laparoscopic PVL is a safe and effective alternative to PVE in patients with contrast contraindications.
  • Expression of Signal Regulatory Protein Alpha in Tumor Cells is the Key Factor in Intrahepatic Cholangiocarcinoma.
    Katsuya Toshida; Shinji Itoh; Yuki Nakayama; Kyohei Yugawa; Takuma Ishikawa; Yuriko Tsutsui; Takahiro Tomiyama; Norifumi Iseda; Sunao Fujiyoshi; Takashi Motomura; Takeo Toshima; Takeshi Iwasaki; Yoshinao Oda; Tomoharu Yoshizumi
    Annals of surgical oncology, 32, 10, 8037, 8045, Oct. 2025, [International Magazine]
    English, Scientific journal, BACKGROUND: Signal-regulatory protein alpha (SIRPα) has recently garnered attention for its role in the immune system, commonly referred to as the "don't eat me" signal. However, the relationship between SIRPα expression in tumor cells and prognosis in patients undergoing hepatectomy for intrahepatic cholangiocarcinoma (ICC) has been scarcely reported. PATIENTS AND METHODS: A total of 117 patients who underwent hepatectomy for ICC were enrolled in this study. Immunohistochemical staining was performed to evaluate SIRPα, programmed cell death-ligand 1 (PD-L1), and cluster of differentiation 8 (CD8). The relationships between SIRPα expression, clinicopathological characteristics, and patient outcomes were analyzed. RESULTS: The macrophage-SIRPα-positive group exhibited a higher rate of lymph node metastasis (p = 0.0013). The tumor-cell-SIRPα-positive group showed lower carcinoembryonic antigen levels (p = 0.0068) and fewer cases of the perihilar type (p = 0.0165). In multivariate analysis, SIRPα positivity in tumor cells was identified as an independent prognostic factor for both disease-free survival (p = 0.0198) and overall survival (p = 0.0089). Notably, SIRPα positivity in tumor cells showed no significant correlation with PD-L1 expression or CD8-positive tumor-infiltrating T cells in ICC. CONCLUSIONS: Our findings demonstrate that SIRPα expression in tumor cells is more critical than its expression in macrophages for predicting the prognosis of patients with ICC following hepatic resection.
  • A randomized comparative study evaluating water-jet with CUSA for parenchymal dissection in living-donor liver procurement: WORLD trial.
    Takeo Toshima; Shinji Itoh; Takashi Motomura; Kyohei Yugawa; Yuriko Tsutsui; Sunao Fujiyoshi; Mototsugu Shimokawa; Tomoharu Yoshizumi
    International journal of surgery protocols, 29, 3, 82, 87, Sep. 2025, [International Magazine]
    English, Scientific journal, INTRODUCTION: Water-Jet (WJ) dissection is an innovative technique for liver surgery that uses high-pressure saline jets to selectively dissect liver parenchyma while preserving vascular and biliary structures. Compared to the Cavitron Ultrasonic Surgical Aspirator (CUSA), WJ offers advantages such as reduced thermal damage, lower blood loss, and shorter operative times. These benefits are particularly important in living-donor liver transplantation (LDLT), where donor safety and rapid recovery are critical. This WORLD trial ("W"ater-Jet versus CUSA f"o"r Liver Pa"r"enchymal Transection in "L"iving "D"onor Liver Transplantation) aims to compare the efficacy and safety of WJ and CUSA in LDLT. METHODS AND ANALYSIS: This single-blind, randomized controlled trial will include 48 living liver donors, allocated in a 1:1 ratio to the WJ or CUSA group. Experienced surgeons will perform liver parenchymal transection using standardized protocols. The primary endpoint is transection speed (cm2/min), with secondary outcomes including operative time, blood loss, complication rates, length of postoperative hospital stays, and postoperative liver function tests. Statistical analysis will assess the non-inferiority of WJ using JMP and R software, with a one-sided α of 2.5% and 80% power. ETHICS AND DISSEMINATION: This study protocol was approved by the institutional review board of Kyushu University (No. 20232001). The study is registered in UMIN-CTR as UMIN000051662. Written informed consent will be obtained from all participants. The results will be published in a peer-reviewed journal and will be presented at medical meetings.
  • 直腸および肛門管癌における経会陰超音波検査の診断可能範囲と有用性に関する検討
    今泉 健; 吉田 雅; 西田 睦; 堀江 達則; 柴田 賢吾; 藤好 直; 市川 伸樹; 本間 重紀; 武冨 紹信
    日本消化器外科学会雑誌, 57, Suppl.2, 256, 256, (一社)日本消化器外科学会, Nov. 2024
    Japanese
  • 高齢者大腸癌への鏡視下右側結腸切除術における呼吸器合併症と術後死亡の検討
    南波 宏征; 今泉 健; 本間 重紀; 吉田 雅; 市川 伸樹; 藤好 直; 柴田 賢吾; 下國 達志; 笠島 浩行; 中西 一彰; 武冨 紹信
    日本消化器外科学会雑誌, 57, Suppl.2, 493, 493, (一社)日本消化器外科学会, Nov. 2024
    Japanese
  • Role of Heavy Water in Modified University of Wisconsin Solution for Extended Cold Storage of Rat Liver.
    Moto Fukai; Kengo Shibata; Sodai Sakamoto; Takahisa Ishikawa; Norio Kawamura; Masato Fujiyoshi; Sunao Fujiyoshi; Kosei Nakamura; Hiroki Bochimoto; Shingo Shimada; Tsuyoshi Shimamura; Akinobu Taketomi
    Transplantation proceedings, 56, 8, 1890, 1895, Oct. 2024, [International Magazine]
    English, Scientific journal, To resolve the critical donor shortage worldwide, enlarging the potential donor pool to include expanded criteria donors is necessary. Despite numerous attempts to establish new preservation solutions, no dramatic innovation has occurred since University of Wisconsin (UW) solution displaced Euro Collins' solution; UW solution remains the global gold standard. We previously developed a heavy water (D2O)-containing organ storage solution, Dsol, which is effective for livers subjected to extended cold storage (CS), and reported its effectiveness. Dsol is a modified UW solution; however, the substances or conditions that exhibit a synergistic or additive effect with D2O are unclear. Here we made UWD solution by removing hydroxyethyl starch (HES) from and adding 30%-D2O to UW solution, and compared the effects of these solutions. After 48 hours of CS, the livers were reperfused at 37 °C on an isolated perfused rat liver apparatus, and their perfusion kinetics, functions, and injuries were compared. In the UW group, portal vein resistance significantly increased and the oxygen consumption rate and bile production decreased; in contrast, these changes were suppressed in the UWD group. Organ expansion and liver damage progressed in both groups. These results confirmed that the removal of HES from and addition of D2O to the UW solution reduced CS-induced cellular function impairments and microcirculatory disorders. However, to reduce injury during reperfusion after CS, it is necessary to provide conditions that inhibit injury progression after reperfusion.
  • Appendiceal goblet cell adenocarcinoma with perineural invasion extending into the ileocecal lesion.
    Yuka Hosokawa; Sunao Fujiyoshi; Ken Imaizumi; Kengo Shibata; Nobuki Ichikawa; Tadashi Yoshida; Shigenori Homma; Takeaki Kudo; Nanase Okazaki; Utano Tomaru; Akinobu Taketomi
    Surgical case reports, 10, 1, 183, 183, 07 Aug. 2024, [International Magazine]
    English, Scientific journal, BACKGROUND: Appendiceal goblet cell adenocarcinoma (GCA) is a rare subtype of primary appendiceal adenocarcinoma with an incidence of 1-5 per 10,000,000 people per year. Appendiceal tumors are often diagnosed after appendectomy for acute appendicitis. Notably, however, there is currently no standard treatment strategy for GCA, including additional resection. We report a case of appendiceal GCA with perineural extension into the cecum, in which ileal resection was considered effective. CASE PRESENTATION: A 41-year-old man was diagnosed with acute appendicitis and underwent appendectomy. Histopathological findings revealed GCA (T3, Pn1). He was referred to our hospital for additional resection. Preoperative examination indicated a diagnosis of GCA cT3N0M0. Laparoscopic ileocecal resection and D3 lymph node dissection were performed 2 months after initial appendectomy. The patient had a good postoperative course and was discharged 8 days after surgery. Histopathological findings showed a GCA invading the cecum, despite an intact appendiceal stump, no lymph node metastasis, no vascular invasion, and no horizontal extension into the submucosa. Direct invasion of the tumor through the serosa was not observed, but perineural extension was conspicuous in the cecum, suggesting that the GCA extended into the cecum via perineural invasion. The resection margins were negative. The patient has survived free of recurrence for a year after ileocecal resection. CONCLUSIONS: The current patient was diagnosed with appendiceal GCA following appendectomy for acute appendicitis. Despite intact of appendiceal stump and no evidence of lymph node or distant metastasis, he underwent laparoscopic ileocecal resection and D3 lymph node dissection 2 months after initial appendectomy, with a favorable outcome. Despite the detection of perineural invasion, the patient declined adjuvant therapy. This case suggests that extensive resection may be required in patients with appendiceal GCA, but the role of adjuvant therapy remains unclear.
  • 人工肛門閉鎖術における単回使用創傷治療システムを用いて遷延性縫合閉鎖を行う皮膚閉鎖方法
    今泉 健; 本間 重則; 柴田 賢吾; 藤好 直; 市川 伸樹; 吉田 雅; 下國 達志; 笠島 浩行; 中西 一彰; 武冨 紹信
    日本消化器外科学会総会, 79回, 743, 743, (一社)日本消化器外科学会, Jul. 2024
    Japanese
  • 脾彎曲結腸癌に対する郭清成績と長期予後に関する検討
    市川 伸樹; 本間 重紀; 吉田 雅; 藤好 直; 柴田 賢吾; 今泉 健; 武冨 紹信
    日本大腸肛門病学会雑誌, 77, 6, 382, 382, (一社)日本大腸肛門病学会, Jun. 2024
    Japanese
  • 当科におけるロボット支援下直腸癌切除の中期成績
    市川 伸樹; 本間 重紀; 吉田 雅; 藤好 直; 柴田 賢吾; 今泉 健; 武冨 紹信
    日本大腸肛門病学会雑誌, 77, 4, 240, 240, (一社)日本大腸肛門病学会, Apr. 2024
    Japanese
  • 鏡視下手術に対する最適な静脈血栓塞栓症予防 腹腔鏡下胃癌大腸癌周術期における静脈血栓塞栓症発症リスク因子の検討
    市川 伸樹; 本間 重紀; 吉田 雅; 藤好 直; 柴田 賢吾; 今泉 健; 蒲池 浩文; 川村 秀樹; 横田 良一; 大野 陽介; 舩越 徹; 前田 好章; 武冨 紹信
    日本外科学会定期学術集会抄録集, 124回, WS, 1, (一社)日本外科学会, Apr. 2024
    Japanese
  • 鏡視下手術に対する最適な静脈血栓塞栓症予防 潰瘍性大腸炎に対する腹腔鏡下大腸切除後の門脈血栓症のリスク因子の解明および周術期予防法についての後方視的検討
    今泉 健; 本間 重紀; 柴田 賢吾; 藤好 直; 市川 伸樹; 武冨 紹信
    日本外科学会定期学術集会抄録集, 124回, WS, 2, (一社)日本外科学会, Apr. 2024
    Japanese
  • 大腸がんの再発・転移におけるメトホルミンの抗腫瘍効果およびT細胞誘導メカニズムの解明
    木村 沙織; 本間 重紀; 白川 智沙斗; 中本 裕紀; 志智 俊介; 松井 博紀; 柴田 賢吾; 藤好 直; 市川 伸樹; 吉田 雅; 北村 秀光; 武冨 紹信
    日本外科学会定期学術集会抄録集, 124回, SF, 3, (一社)日本外科学会, Apr. 2024
    Japanese
  • ラット肝温阻血再灌流障害におけるUDPNアセチルヘキソサミンの動態
    柴田 賢吾; 深井 原; 今泉 健; 藤好 直; 坂本 聡大; 市川 伸樹; 吉田 雅; 川村 典夫; 藤好 真人; 本間 重紀; 嶋村 剛; 武冨 紹信
    日本外科学会定期学術集会抄録集, 124回, SF, 4, (一社)日本外科学会, Apr. 2024
    Japanese
  • 切除不能転移性大腸癌原発巣切除例のリンパ球/単球比と予後の検討
    和久井 洋佑; 市川 伸樹; 今泉 健; 柴田 賢吾; 藤好 直; 吉田 雅; 本間 重紀; 武冨 紹信
    日本外科学会定期学術集会抄録集, 124回, SF, 4, (一社)日本外科学会, Apr. 2024
    Japanese
  • E-PASSを用いた高齢者の腹腔鏡下右側結腸切除術における術後合併症リスク因子の検討
    南波 宏征; 今泉 健; 本間 重紀; 吉田 雅; 市川 伸樹; 藤好 直; 柴田 賢吾; 武冨 紹信
    日本外科学会定期学術集会抄録集, 124回, PS, 6, (一社)日本外科学会, Apr. 2024
    Japanese
  • 潰瘍性大腸炎関連腫瘍に対するロボット支援下大腸全摘術
    本間 重紀; 今泉 健; 柴田 賢吾; 藤好 直; 市川 伸樹; 吉田 雅; 武冨 紹信
    日本外科学会定期学術集会抄録集, 124回, PS, 4, (一社)日本外科学会, Apr. 2024
    Japanese
  • 神経周囲浸潤により回盲部へ進展を認めた虫垂goblet cell adenocarcinomaの一例
    細川 侑香; 藤好 直; 今泉 健; 柴田 賢吾; 岡崎 ななせ; 中里 信一; 市川 伸樹; 吉田 雅; 本間 重紀; 武冨 紹信
    日本外科学会定期学術集会抄録集, 124回, RS, 1, (一社)日本外科学会, Apr. 2024
    Japanese
  • von Willebrand病に併存した小腸間膜裂孔ヘルニアによる絞扼性イレウスの一例
    田中 奨真; 柴田 賢吾; 今泉 健; 藤好 直; 市川 伸樹; 吉田 雅; 本間 重紀; 武冨 紹信
    日本外科学会定期学術集会抄録集, 124回, RS, 4, (一社)日本外科学会, Apr. 2024
    Japanese
  • 新型コロナウイルス感染を契機に増悪し大腸亜全摘を施行した潰瘍性大腸炎の1例
    長安 健; 藤好 直; 本間 重紀; 市川 伸樹; 吉田 雅; 柴田 賢吾; 松井 博紀; 桂田 武彦; 中久保 祥; 畑中 佳奈子; 武冨 紹信
    日本消化器外科学会雑誌, 57, 4, 204, 211, (一社)日本消化器外科学会, Apr. 2024
    Japanese
  • 切除不能転移性大腸癌原発巣切除例のリンパ球/単球比と予後の検討
    和久井 洋佑; 市川 伸樹; 今泉 健; 柴田 賢吾; 藤好 直; 吉田 雅; 本間 重紀; 武冨 紹信
    日本外科学会定期学術集会抄録集, 124回, SF, 4, (一社)日本外科学会, Apr. 2024
    Japanese
  • E-PASSを用いた高齢者の腹腔鏡下右側結腸切除術における術後合併症リスク因子の検討
    南波 宏征; 今泉 健; 本間 重紀; 吉田 雅; 市川 伸樹; 藤好 直; 柴田 賢吾; 武冨 紹信
    日本外科学会定期学術集会抄録集, 124回, PS, 6, (一社)日本外科学会, Apr. 2024
    Japanese
  • 潰瘍性大腸炎関連腫瘍に対するロボット支援下大腸全摘術
    本間 重紀; 今泉 健; 柴田 賢吾; 藤好 直; 市川 伸樹; 吉田 雅; 武冨 紹信
    日本外科学会定期学術集会抄録集, 124回, PS, 4, (一社)日本外科学会, Apr. 2024
    Japanese
  • 重水含有臓器保存液の有効成分の検証 体外灌流によるグラフト機能評価
    深井 原; 柴田 賢吾; 坂本 聡大; 石川 隆壽; 藤好 真人; 藤好 直; 川村 典生; 島田 慎吾; 嶋村 剛; 武冨 紹信
    日本外科学会定期学術集会抄録集, 124回, PS, 7, (一社)日本外科学会, Apr. 2024
    Japanese
  • 神経周囲浸潤により回盲部へ進展を認めた虫垂goblet cell adenocarcinomaの一例
    細川 侑香; 藤好 直; 今泉 健; 柴田 賢吾; 岡崎 ななせ; 中里 信一; 市川 伸樹; 吉田 雅; 本間 重紀; 武冨 紹信
    日本外科学会定期学術集会抄録集, 124回, RS, 1, (一社)日本外科学会, Apr. 2024
    Japanese
  • von Willebrand病に併存した小腸間膜裂孔ヘルニアによる絞扼性イレウスの一例
    田中 奨真; 柴田 賢吾; 今泉 健; 藤好 直; 市川 伸樹; 吉田 雅; 本間 重紀; 武冨 紹信
    日本外科学会定期学術集会抄録集, 124回, RS, 4, (一社)日本外科学会, Apr. 2024
    Japanese
  • SGLT2 is upregulated to acquire cisplatin resistance and SGLT2 inhibition reduces cisplatin resistance in hepatoblastoma.
    Sunao Fujiyoshi; Shohei Honda; Momoko Ara; Takafumi Kondo; Nozomi Kobayashi; Akinobu Taketomi
    Journal of hepato-biliary-pancreatic sciences, 31, 4, 223, 233, Apr. 2024, [Domestic magazines]
    English, Scientific journal, BACKGROUND: Cancer cells can alter glucose metabolism and regulate the expression of glucose transporters. Hepatoblastoma patients undergo cisplatin-based chemotherapy; however, 22.3% of patients develop cisplatin resistance and thus face a poor prognosis. We hypothesized that glucose transporters are associated with acquiring cisplatin resistance with increasing sugar intake inhibiting glucose transporters could reduce cisplatin resistance in hepatoblastoma patients. METHODS: We established cisplatin-resistant HepG2 and HuH6 cells by continuous treatment with cisplatin. We evaluated the relationship between cisplatin resistance and glucose uptake. We used an expression array to select cisplatin-resistant associated glucose transporters and selected sodium-glucose cotransporter 2 (SGLT2). We used dapagliflozin as an SGLT2 inhibitor and evaluated glucose uptake and IC50 after dapagliflozin treatment in wild-type and resistant hepatoblastoma cells in vitro and in vivo. RESULTS: We found a strong relationship between cisplatin resistance and glucose uptake. Additionally, SGLT2 was upregulated in resistant cells after cisplatin treatment. After dapagliflozin treatment, glucose uptake and cisplatin resistance decreased in resistant cells. CONCLUSIONS: Cisplatin-resistant hepatoblastoma cells exhibited upregulated SGLT2 expression and activated glucose uptake to survive under cisplatin stress. SGLT2 inhibition decreased cellular resistance to cisplatin. SGLT2 inhibition with cisplatin therapy could be a novel therapeutic strategy for cisplatin-resistant hepatoblastoma patients.
  • 腸管切除後出血のリスク因子の検討
    坂村 颯真; 本間 重紀; 吉田 雅; 市川 伸樹; 藤好 直; 柴田 賢吾; 松井 博紀; 武冨 紹信
    日本臨床外科学会雑誌, 85, 2, 297, 297, 日本臨床外科学会, Feb. 2024
    Japanese
  • 高齢潰瘍性大腸炎に対する手術成績
    吉田 雅; 本間 重紀; 市川 伸樹; 藤好 直; 柴田 賢吾; 松井 博紀; 武冨 紹信
    日本臨床外科学会雑誌, 85, 2, 298, 298, 日本臨床外科学会, Feb. 2024
    Japanese
  • 非外傷性S状結腸間膜血種に対し,左半結腸切除術を施行した1例
    津坂 隼也; 柴田 賢吾; 今泉 健; 藤好 直; 市川 伸樹; 吉田 雅; 本間 重紀; 武冨 紹信
    日本腹部救急医学会雑誌, 44, 2, 456, 456, (一社)日本腹部救急医学会, Feb. 2024
    Japanese
  • Important Constituents of Heavy Water-containing Solution for Cold Storage and Subsequent Reperfusion on an Isolated Perfused Rat Liver.
    Moto Fukai; Sodai Sakamoto; Kengo Shibata; Takahisa Ishikawa; Norio Kawamura; Masato Fujiyoshi; Sunao Fujiyoshi; Kosei Nakamura; Hiroki Bochimoto; Shingo Shimada; Tsuyoshi Shimamura; Akinobu Taketomi
    Transplantation proceedings, 09 Jan. 2024, [International Magazine]
    English, Scientific journal, The University of Wisconsin (UW) solution is the most effective preservation solution currently used; however, to safely use expanded-criteria donor grafts, a new cold storage solution that alleviates graft injury more effectively is required. We prepared a heavy water (D2O)-containing buffer, Dsol, and observed strong protective effects during extended cold storage of rat hearts and livers. In the current study, we modified Dsol (mDsol) and tested its efficacy. The aim of the present study was to determine whether mDsol could protect the rat liver more effectively than the UW solution and to clarify the roles of D2O and deferoxamine (DFX). Rat livers were subjected to cold storage for 48 hours in test solutions: UW, mDsol, mDsol without D2O or DFX (mDsol-D2O[-], mDsol-DFX[-]), and subsequently reperfused on an isolated perfused rat liver for 90 minutes at 37°C. In the UW group, the liver was dehydrated during cold storage and rapidly expanded during reperfusion. Accordingly, the cumulative weight change was the highest in the UW group, together with augmented portal veinous resistance and ALT leakage and decreased oxygen consumption rate and bile production. These changes were significantly suppressed in the mDsol-treated group. In the mDsol-D2O(-) and mDsol-DFX(-) groups offered partial protection. In conclusion, mDsol appeared to be superior to the UW solution for simple cold storage of the rat liver, presumably due to improved microcirculation in the early phase of reperfusion. Both heavy water and deferoxamine are essential for alleviating seamless organ swelling that occurs during cold storage and subsequent reperfusion.
  • ラット肝の27℃体外灌流における至適灌流pHの検討
    中村 恒星; 深井 原; 藤好 真人; 藤好 直; 柴田 賢吾; 坂本 聡大; 川村 典生; 後藤 了一; 長津 明久; 渡辺 正明; 嶋村 剛; 武冨 紹信
    移植, 59, Supplement, s291_3, s291_3, 一般社団法人 日本移植学会, 2024
    Japanese, 【背景】 易傷害性肝グラフトに対する機械灌流の有用性が報告されたが、灌流時の液組成、温度、pH等の条件検討は不十分である。我々は7℃での肝体外灌流の至適pHを既に報告したが (坂本 2023 J Clin Med)、異なる温度でのMPにおける至適pHは明らかではない。【目的】 27℃の肝機械灌流における至適灌流pHを明らかにすること。【方法】 ラット肝をUW液中で48時間の冷保存(CS)後、UWMP液で27℃, 3時間酸素化灌流(MP)し、さらに単離ラット肝灌流装置で37℃, 90分再灌流した。実験群: CSせずに再灌流 (CT群); MPなしで再灌流 (CS群); UWMP液でMPする際にpH無調節 (No群); あるいは、UWMP液のpHを7.2~7.6に調節してMP (pH7.2群~7.6群)(各n>6)。再灌流時の肝逸脱酵素、胆汁産生量、酸素消費率、門脈抵抗等を評価した。【結果】 再灌流後の肝逸脱酵素はpH7.4群で最低、No群で最高であった。再灌流時の酸素消費率はCS群では著明に低下したが、全てのMP実施群ではCT群と同等の高値であった。胆汁産生量はCS群、No群で低値、pH7.4群では有意に増加した。肝逸脱酵素はCS群で上昇、No群でも上昇したが、pH7.4群ではCS群と同等であった。pH7.5群はpH7.4群とほぼ同様の結果であった。門脈抵抗値は、全てのpH調節群とCT群、No群間に有意差はなかった。【考察・結語】 温度に応じた至適pHが灌流における重要な条件と考えられた。27℃の肝機械灌流における至適灌流pHは7.4-7.5の範囲と考えられた。
  • ラットにおけるischemia free liver transplantation法の確立
    藤好 直; 藤好 真人; 山本 葉一; 相山 健; 長津 明久; 川村 典生; 渡辺 正明; 後藤 了一; 柿坂 達彦; 深井 原; 嶋村 剛; 武冨 紹信
    移植, 59, Supplement, s344_2, s344_2, 一般社団法人 日本移植学会, 2024
    Japanese, 緒言:肝移植において、機械灌流法は臨床応用の段階にあり、有効性が報告されている。治療的機械灌流の目的は臓器保存環境の最適化であり、体内外での機械灌流により臓器無灌流状態を排除したischemia free liver transplantation (IFLT)法はその究極的な形態の一つである。この方法はGuangzhouグループにより開発され、臨床研究が行われてきたが、技術的要求が高く、基礎研究モデルは未確立である。我々は、ラットIFLTモデルの開発に成功しており、改良により良好な成績を達成したのでここに報告する。方法:ドナー、レシピエントともWister Rat (250g, オス)を用い、灌流形式は経門脈的冷温酸素化機械灌流とした。ドナー肝血流を維持しながら、脾静脈より灌流カテーテル、肝下部下大静脈より排液カテーテルを挿入し、血流遮断と同時に機械灌流を開始し、機械灌流下に摘出および体外保存を行った。レシピエントの肝全摘後、機械灌流下に肝上部下大静脈と門脈を手縫い吻合し、血流再開と同時に機械灌流を停止した。結果:灌流液を冷温細胞外液、保存時間を短時間 (臓器摘出後すぐにレシピエント手術を開始)としたIFLTにおいて、全例でレシピエントの生存が得られた。考察:IFLTは将来性の高い機械灌流法であり、当モデルはその基礎研究に寄与しうるものと考えられる。
  • 神経侵襲による進展を認めた虫垂goblet celladenocarcinomaの1例
    細川 侑香; 藤好 直; 今泉 健; 柴田 賢吾; 市川 伸樹; 吉田 雅; 本間 重紀; 武冨 紹信; 岡崎 ななせ; 中里 信一
    北海道外科雑誌, 68, 2, 146, 146, 北海道外科学会, Dec. 2023
    Japanese
  • Feasibility of Laparoscopic and Robotic Total Proctocolectomy for Ulcerative Colitis-related Colorectal Cancer.
    Tadashi Yoshida; Shigenori Homma; Nobuki Ichikawa; Sunao Fujiyoshi; Kengo Shibata; Ken Imaizumi; Akinobu Taketomi
    Anticancer research, 43, 11, 5245, 5252, Nov. 2023, [International Magazine]
    English, Scientific journal, BACKGROUND/AIM: To evaluate the feasibility of laparoscopic and robotic total proctocolectomy (TPC) for ulcerative colitis-associated colorectal cancer (UC-CRC). PATIENTS AND METHODS: We retrospectively analyzed the postoperative outcomes of TPC in 13 patients with UC-CRC between January 2011 and December 2021. Laparoscopic TPC was performed in 10 patients. TPC consisted of two procedures: ileal pouch-anal anastomosis (IAA) and TPC with end ileostomy. Using the da Vinci Xi platform with six ports, robotic TPC and abdominal perineal resection (APR) were performed in two and one patients, respectively. Transanal total mesorectal excision (TaTME) was performed using the perineal approach in five patients. RESULTS: UC-CRC was located in the transverse colon, sigmoid colon, rectum, and anal canal in 1, 1, 10, and 1 patients, respectively. IAA, TPC with end ileostomy, and APR were performed in nine, three, and one patients, respectively. Postoperative complications included colitis, portal vein thrombosis, and liver dysfunction, without mortality. The pathological stages were 0, I, IIa, IIIb, and IIIc in five, four, one, two, and one patients, respectively. The tumors were completely resected in all cases. Eleven patients with pStages 0, I, and II survived without recurrence; however, two patients with pStage III died of cancer recurrence. CONCLUSION: This study demonstrated the feasibility of laparoscopic and robotic TPC in patients with UC-CRC. However, long-term outcomes in terms of oncology and patient quality of life must be investigated in future large-scale studies.
  • A Study of risk factors of postoperative ileus after laparoscopic colorectal resection.
    Sunao Fujiyoshi; Shigenori Homma; Tadashi Yoshida; Nobuki Ichikawa; Kengo Shibata; Hiroki Matsui; Akinobu Taketomi
    Annals of gastroenterological surgery, 7, 6, 949, 954, Nov. 2023, [Domestic magazines]
    English, Scientific journal, AIM: Postoperative ileus (POI) is a common complication after abdominal surgery. However, the risk factors for POI after laparoscopic colorectal resection are unclear. We therefore investigated the risk factors for POI after laparoscopic colorectal surgery. METHODS: This retrospective study involved 484 patients who underwent laparoscopic surgery for primary colorectal cancer at Hokkaido University Hospital. We categorized the patients into a POI group (n = 19) and non-POI group (n = 465). We compared sex, age, smoking, chronic obstructive pulmonary disease (COPD), diabetes mellitus, body mass index (BMI), cardiac disorder, serum albumin, American Society of Anesthesiologists-physical status, tumor location, tumor stage, operative duration, stoma formation, lymph node dissection, operator, and bleeding as potential risk factors for POI between the POI group and non-POI group by univariate and multivariate analyses. RESULTS: The univariate analysis results showed that the POI group had a higher incidence of male sex (P = 0.036), COPD (P = 0.029), and a BMI of <20 kg/m2 (P = 0.0487) as well as a higher bleeding volume (P = 0.014). The multivariate analysis results showed that male sex (odds ratio [OR], 0.2799; 95% confidence interval [CI], 0.089-0.993; P = 0.0298), COPD (0.2866; 0.095-0.862; P = 0.0262), and a BMI of <20 kg/m2 (0.2985; 0.112-0.794; P = 0.0154) were independent risk factors for POI after laparoscopic colorectal resection. CONCLUSION: Our findings suggest that male sex, COPD, and a BMI of <20 kg/m2 are independent risk factors for POI after laparoscopic colorectal surgery for treatment of colorectal cancer.
  • 臓器保存の生物学と技術 機械灌流中の最適pHは温度によって変化する(Organ preservation Biology and technology The optimal pH during machine perfusion varies depending on the temperature)
    深井 原; 柴田 賢吾; 藤好 直; 川村 典生; 本井 慧路; 藤好 真人; 石川 隆壽; 中村 恒星; 暮地本 宙己; 嶋村 剛; 武冨 紹信
    Organ Biology, 30, 3, 52, 52, (一社)日本臓器保存生物医学会, Oct. 2023
    English
  • 大腸がんの再発・転移におけるメトホルミンの抗腫瘍免疫に及ぼす効果
    木村 沙織; 本間 重紀; 白川 智沙斗; 中本 裕紀; 志智 俊介; 今泉 健; 柴田 賢吾; 藤好 直; 市川 伸樹; 吉田 雅; 北村 秀光; 武冨 紹信
    日本がん免疫学会総会プログラム・抄録集, 27回, 105, 105, 日本がん免疫学会, Jun. 2023
    Japanese
  • Combination of Cold Storage in a Heavy Water-Containing Solution and Post-Reperfusion Hydrogen Gas Treatment Reduces Ischemia-Reperfusion Injury in Rat Livers.
    Moto Fukai; Sodai Sakamoto; Kengo Shibata; Masato Fujiyoshi; Sunao Fujiyoshi; Hiroki Bochimoto; Takahisa Ishikawa; Shingo Shimada; Kosei Nakamura; Norio Kawamura; Tsuyoshi Shimamura; Akinobu Taketomi
    Transplantation proceedings, 55, 4, 1027, 1031, May 2023, [International Magazine]
    English, Scientific journal, We previously reported the efficacy of cold storage (CS) using a heavy water-containing solution (Dsol) and post-reperfusion hydrogen gas treatment separately. This study aimed to clarify the combined effects of these treatments. Rat livers were subjected to 48-hour CS and a subsequent 90-minute reperfusion in an isolated perfused rat liver system. The experimental groups were the immediately reperfused control group (CT), the CS with University of Wisconsin solution (UW) group, the CS with Dsol group, the CS with UW and post-reperfusion H2 treatment group (UW-H2), and the CS with Dsol and post-reperfusion H2 group (Dsol-H2). We first compared the Dsol-H2, UW, and CT groups to evaluate this alternative method to conventional CS. The protective potential of the Dsol-H2 group was superior to that of the UW group, as evidenced by lower portal venous resistance and lactate dehydrogenase leakage, a higher oxygen consumption rate, and increased bile production. Multiple comparison tests among the UW, Dsol, UW-H2, and Dsol-H2 groups revealed that both treatments, during CS and after reperfusion, conferred a similar extent of protection and showed additive effects in combination therapy. Furthermore, the variance in all treatment groups appeared smaller than that in the no-treatment or no-stress groups, with excellent reproducibility. In conclusion, combination therapy with Dsol during CS and hydrogen gas after reperfusion additively protects against graft injury.
  • ハイリスク症例に対する術前リスク評価の重要性 ハイリスク高齢者直腸癌症例に対する術式選択
    吉田 雅; 本間 重紀; 市川 伸樹; 藤好 直; 柴田 賢吾; 松井 博紀; 武冨 紹信
    日本外科系連合学会誌, 48, 3, 318, 318, 日本外科系連合学会, May 2023
    Japanese
  • 大腸憩室に対する姑息的人工肛門造設術の検討
    柴田 賢吾; 松井 博紀; 藤好 直; 市川 伸樹; 吉田 雅; 本間 重紀; 武冨 紹信
    日本外科系連合学会誌, 48, 3, 436, 436, 日本外科系連合学会, May 2023
    Japanese
  • 腸管切除後出血のリスク因子の検討
    藤好 直; 本間 重紀; 吉田 雅; 市川 伸樹; 柴田 賢吾; 松井 博紀; 武冨 紹信
    日本外科系連合学会誌, 48, 3, 427, 427, 日本外科系連合学会, May 2023
    Japanese
  • Rapid and Reliable Steatosis Rat Model Shrsp5-Dmcr for Cold Storage Experiment.
    Moto Fukai; Hiroyuki Sugimori; Sodai Sakamoto; Kengo Shibata; Hiroyuki Kameda; Takahisa Ishikawa; Norio Kawamura; Masato Fujiyoshi; Sunao Fujiyoshi; Kohsuke Kudo; Tsuyoshi Shimamura; Akinobu Taketomi
    Transplantation proceedings, 55, 4, 1032, 1035, 10 Apr. 2023, [International Magazine]
    English, Scientific journal, Interventions for liver grafts with moderate macrovesicular steatosis have been important in enlarging donor pools. Here, we tested a high-fat and cholesterol (HFC) diet to create a steatosis model for cold hepatic preservation and reperfusion experiments. The aim of the present study was to assess the steatosis model's reliability and to show the resulting graft's quality for cold preservation and reperfusion experiment. Male SHRSP5-Dmcr rats were raised with an HFC diet for up to 2 weeks. The fat content was evaluated using magnetic resonance imaging (MRI) proton density fat fraction (PDFF). The nonalcoholic fatty liver disease activity score (NAS) was evaluated after excision. Steatosis created by 2 weeks of HFC diet was subjected to 24-hour cold storage in the University of Wisconsin and the original test solution (new sol.). Grafts were applied to isolated perfused rat livers for simulating reperfusion. The NAS were 2.2 (HFC 5 days), 3.3 (HFC 1 week), and 5.0 (HFC 2 weeks). Ballooning and fibrosis were not observed in any group. An MRI-PDFF showed 0.2 (HFC 0 days), 12.0 (HFC 1 week), and 18.9 (HFC 2 weeks). The NAS and MRI-PDFF values correlated. Many indices in the isolated perfused rat liver experiment tended to improve in the new sol. group but were insufficient. Although the new sol. failed to be effective, it acted at multiple sites under difficult conditions. In conclusion, the HFC diet for 2 weeks in SHRSP5-Dmcr rats, together with MRI-PDFF evaluation, is a reliable method for creating simple steatosis and provides good-quality cold preservation and reperfusion experiments.
  • 大腸がんの再発転移におけるメトホルミンの免疫学的作用メカニズムの解明
    木村 沙織; 本間 重紀; 白川 智沙斗; 中本 裕紀; 志智 俊介; 松井 博紀; 柴田 賢吾; 藤好 直; 市川 伸樹; 吉田 雅; 北村 秀光; 武冨 紹信
    日本外科学会定期学術集会抄録集, 123回, SF, 3[Y], (一社)日本外科学会, Apr. 2023
    Japanese
  • 新型コロナウイルス感染をきっかけに増悪し大腸亜全摘に至った潰瘍性大腸炎の一例
    長安 健; 藤好 直; 本間 重紀; 市川 伸樹; 吉田 雅; 柴田 賢吾; 松井 博紀; 八木 駿; 武冨 紹信; 中久保 祥; 畑中 佳奈子
    日本外科学会定期学術集会抄録集, 123回, RS, 3, (一社)日本外科学会, Apr. 2023
    Japanese
  • 線維性癌間質反応による大腸癌術後補助化学療法の適正化
    八木 駿; 松井 博紀; 本間 重紀; 吉田 雅; 市川 伸樹; 藤好 直; 柴田 賢吾; 武冨 紹信
    日本外科学会定期学術集会抄録集, 123回, SF, 7, (一社)日本外科学会, Apr. 2023
    Japanese
  • Klintrup gradeに基づいた大腸癌内視鏡的切除術後の外科的追加切除
    松井 博紀; 本間 重紀; 吉田 雅; 市川 伸樹; 藤好 直; 柴田 賢吾; 武冨 紹信
    日本外科学会定期学術集会抄録集, 123回, DP, 1, (一社)日本外科学会, Apr. 2023
    Japanese
  • 低侵襲手術時代の開腹手術の教育
    本間 重紀; 松井 博紀; 柴田 賢吾; 藤好 直; 市川 伸樹; 吉田 雅; 武冨 紹信
    日本外科学会定期学術集会抄録集, 123回, DP, 4, (一社)日本外科学会, Apr. 2023
    Japanese
  • 腹腔鏡下大腸癌手術において,COPD既往は術後麻痺性イレウスのリスク因子となる
    藤好 直; 本間 重紀; 吉田 雅; 市川 伸樹; 柴田 賢吾; 松井 博紀; 武冨 紹信
    日本外科学会定期学術集会抄録集, 123回, DP, 2, (一社)日本外科学会, Apr. 2023
    Japanese
  • 直腸癌手術におけるICG蛍光法を用いた吻合部血流評価法について
    柴田 賢吾; 本間 重紀; 松井 博紀; 藤好 直; 市川 伸樹; 吉田 雅; 武冨 紹信
    日本外科学会定期学術集会抄録集, 123回, DP, 7, (一社)日本外科学会, Apr. 2023
    Japanese
  • 術前に診断しえた小網裂孔ヘルニアの1例
    別所 光; 柴田 賢吾; 松井 博紀; 藤好 直; 市川 伸樹; 吉田 雅; 本間 重紀; 武冨 紹信
    日本外科学会定期学術集会抄録集, 123回, RS, 3, (一社)日本外科学会, Apr. 2023
    Japanese
  • Hypothermic Machine Perfusion with Hydrogen Gas Reduces Focal Injury in Rat Livers but Fails to Restore Organ Function.
    Moto Fukai; Sodai Sakamoto; Hiroki Bochimoto; Nur Khatijah Mohd Zin; Kengo Shibata; Takahisa Ishikawa; Shingo Shimada; Norio Kawamura; Masato Fujiyoshi; Sunao Fujiyoshi; Kosei Nakamura; Tsuyoshi Shimamura; Akinobu Taketomi
    Transplantation proceedings, 55, 4, 1016, 1020, 20 Mar. 2023, [International Magazine]
    English, Scientific journal, BACKGROUND: We have previously reported the efficacy of post-reperfusion H2 gas treatment in cold storage (CS) and subsequent reperfusion of the rat liver. The present study aimed to evaluate the effect of H2 gas treatment during hypothermic machine perfusion (HMP) in rat livers retrieved from donation after circulatory death (DCD) and elucidate the mechanism of action of H2 gas. METHODS: Liver grafts were procured from rats after 30 min of cardiopulmonary arrest. The graft was subjected to HMP for 3 hours at 7°C using Belzer MPS with or without dissolved H2 gas. The graft was reperfused using an isolated perfused rat liver apparatus at 37°C for 90 minutes. Perfusion kinetics, liver damage, function, apoptosis, and ultrastructure were evaluated. RESULTS: Portal venous resistance, bile production, and oxygen consumption rates were identical in the CS, MP, and MP-H2 groups. Liver enzyme leakage was suppressed by MP (vs control), whereas H2 treatment did not show a combination effect. Histopathology revealed poorly stained areas with a structural deformity just below the liver surface in the CS and MP groups, whereas these findings disappeared in the MP-H2 group. The apoptotic index in the CS and MP groups was high but decreased in the MP-H2 group. Mitochondrial cristae were damaged in the CS group but preserved in the MP and MP-H2 groups. CONCLUSIONS: In conclusion, HMP and H2 gas treatment are partly effective in DCD rat livers but insufficient. Hypothermic machine perfusion can improve focal microcirculation and preserve mitochondrial ultrastructure.
  • 直腸癌術前放射線化学療法施行例における内視鏡的完全奏功所見の検討
    市川 伸樹; 本間 重紀; 吉田 雅; 藤好 直; 松井 博紀; 柴田 賢吾; 武冨 紹信
    日本大腸肛門病学会雑誌, 76, 2, 226, 226, (一社)日本大腸肛門病学会, Feb. 2023
    Japanese
  • 新型コロナウイルス感染を契機に増悪し大腸亜全摘を施行した潰瘍性大腸炎の1例
    藤好 直; 本間 重紀; 吉田 雅; 市川 伸樹; 柴田 賢吾; 松井 博紀; 武冨 紹信
    日本大腸肛門病学会雑誌, 76, 2, 252, 252, (一社)日本大腸肛門病学会, Feb. 2023
    Japanese
  • 経直腸ドレナージ後に待機的腹腔鏡下手術を行った膿瘍形成虫垂炎の1例
    蔵谷 勇樹; 山本 葉一; 木井 修平; 藤好 直; 下國 達志; 小池 雅彦
    日本臨床外科学会雑誌, 84, 1, 96, 101, 日本臨床外科学会, Jan. 2023
    Japanese
  • 日本内視鏡外科学会技術認定取得医によるロボット支援下直腸癌切除成績の時系列変化
    市川 伸樹; 本間 重紀; 吉田 雅; 藤好 直; 柴田 賢吾; 松井 博紀; 武冨 紹信
    日本内視鏡外科学会雑誌, 27, 7, 1341, 1341, (一社)日本内視鏡外科学会, Dec. 2022
    Japanese
  • 術前化学放射線療法後直腸癌のロボット支援下手術における骨盤MRIの有用性
    松井 博紀; 本間 重紀; 吉田 雅; 市川 伸樹; 藤好 直; 柴田 賢吾; 武冨 紹信
    日本内視鏡外科学会雑誌, 27, 7, 2445, 2445, (一社)日本内視鏡外科学会, Dec. 2022
    Japanese
  • 潰瘍性大腸炎合併colitic cancerに対する鏡視下大腸全摘術
    吉田 雅; 本間 重紀; 市川 伸樹; 藤好 直; 柴田 賢吾; 松井 博紀; 武冨 紹信
    日本内視鏡外科学会雑誌, 27, 7, 2973, 2973, (一社)日本内視鏡外科学会, Dec. 2022
    Japanese
  • serrated polyposis syndromeを背景とした進行性大腸癌の1例
    棟方 裕貴; 藤好 直; 本間 重紀; 吉田 雅; 市川 伸樹; 柴田 賢吾; 松井 博紀; 武冨 紹信
    日本臨床外科学会雑誌, 83, 12, 2121, 2121, 日本臨床外科学会, Dec. 2022
    Japanese
  • 線維性癌間質反応による大腸癌術後補助化学療法の適正化
    八木 駿; 松井 博紀; 本間 重紀; 吉田 雅; 市川 伸樹; 藤好 直; 柴田 賢吾; 武富 紹信
    日本臨床外科学会雑誌, 83, 12, 2122, 2122, 日本臨床外科学会, Dec. 2022
    Japanese
  • 術前に診断しえた小網裂孔ヘルニアの1例
    別所 光; 柴田 賢吾; 松井 博紀; 藤好 直; 市川 伸樹; 吉田 雅; 本間 重紀; 武冨 紹信
    北海道外科雑誌, 67, 2, 175, 175, 北海道外科学会, Dec. 2022
    Japanese
  • 新型コロナウイルス感染を契機に増悪し大腸亜全摘を施行した潰瘍性大腸炎の1例
    長安 健; 藤好 直; 本間 重紀; 市川 伸樹; 吉田 雅; 柴田 賢吾; 松井 博紀; 八木 駿; 武冨 紹信
    北海道外科雑誌, 67, 2, 186, 186, 北海道外科学会, Dec. 2022
    Japanese
  • 腹腔鏡下大腸癌手術において、COPD既往は術後腸管麻痺症のリスク因子となる
    藤好 直; 本間 重紀; 吉田 雅; 市川 伸樹; 柴田 賢吾; 松井 博紀; 武冨 紹信
    日本内視鏡外科学会雑誌, 27, 7, 1739, 1739, (一社)日本内視鏡外科学会, Dec. 2022
    Japanese
  • ステージII大腸癌における静脈侵襲の再発に与える影響の検討
    市川 伸樹; 本間 重紀; 吉田 雅; 藤好 直; 松井 博紀; 柴田 賢吾; 武冨 紹信
    日本癌治療学会学術集会抄録集, 60回, O52, 2, (一社)日本癌治療学会, Oct. 2022
    English
  • 内科・外科による消化器病共同診療の現況と展望 当院における潰瘍性大腸炎に対する手術成績
    吉田 雅; 本間 重紀; 市川 伸樹; 藤好 直; 柴田 賢吾; 松井 博紀; 桂田 武彦; 桜井 健介; 福島 新弥; 青山 慶哉; 坂本 直哉; 武冨 紹信
    日本消化器病学会北海道支部例会・日本消化器内視鏡学会北海道支部例会プログラム・抄録集, 131回・125回, 26, 26, 日本消化器病学会-北海道支部, Sep. 2022
    Japanese
  • ステージII大腸癌における脈管侵襲の再発に与える影響の検討
    松井 博紀; 本間 重紀; 吉田 雅; 藤好 直; 市川 伸樹; 柴田 賢吾; 武冨 紹信
    日本大腸肛門病学会雑誌, 75, 9, A201, A201, (一社)日本大腸肛門病学会, Sep. 2022
    Japanese
  • 内科・外科による消化器病共同診療の現況と展望 局所進行直腸癌における術前FOLFOX療法の有効性の検討(RNAC01試験)の解釈とその発展
    藤好 直; 本間 重紀; 市川 伸樹; 結城 敏志; 川本 泰之; 原田 一顕; 吉田 雅; 柴田 賢吾; 松井 博紀; 小松 嘉人; 坂本 直哉; 武冨 紹信
    日本消化器病学会北海道支部例会・日本消化器内視鏡学会北海道支部例会プログラム・抄録集, 131回・125回, 26, 26, 日本消化器病学会-北海道支部, Sep. 2022
    Japanese
  • 経皮経肝門脈右枝塞栓後にcoronavirus disease 2019に罹患した盲腸癌肝転移の治癒的切除例
    藤好 直; 柿坂 達彦; 松澤 文彦; 下國 達志; 木井 修平; 蔵谷 勇樹; 西川 眞; 森田 亮; 中西 勝也; 高木 智史; 高橋 昌宏
    日本消化器外科学会雑誌, 55, 6, 389, 398, (一社)日本消化器外科学会, Jun. 2022
    Japanese
  • PTPE後に中等症COVID-19を罹患したが、呼吸状態改善後に治癒的切除をし得た転移性肝腫瘍の1例
    藤好 直; 柿坂 達彦; 下國 達志; 松澤 文彦; 木井 修平; 蔵谷 勇樹; 西川 眞; 高橋 昌弘
    日本臨床外科学会雑誌, 82, 増刊, S765, S765, 日本臨床外科学会, Oct. 2021
    Japanese
  • A MicroRNA Cluster in the DLK1-DIO3 Imprinted Region on Chromosome 14q32.2 Is Dysregulated in Metastatic Hepatoblastomas
    Shohei Honda; Aniruddha Chatterjee; Anna L. Leichter; Hisayuki Miyagi; Masashi Minato; Sunao Fujiyoshi; Momoko Ara; Norihiko Kitagawa; Mio Tanaka; Yukichi Tanaka; Masato Shinkai; Kanako C. Hatanaka; Akinobu Taketomi; Michael R. Eccles
    Frontiers in Oncology, 10, 513601, 513601, Frontiers Media SA, 12 Nov. 2020, [International Magazine]
    English, Scientific journal, Hepatoblastoma (HB) is the most common malignant liver neoplasm in children. Despite progress in HB therapy, outcomes for patients with metastatic disease remain poor. Dysregulation of miRNA expression is one of the potential epigenetic mechanisms associated with pathogenesis of HB. However, miRNA profiles related to the different stages of HB tissues and cells, in particular of lung metastatic tumor cells, are unknown. In the present study, using array-based miRNA expression and DNA methylation analysis on formalin-fixed paraffin-embedded tissues, we aimed to identify miRNA changes that can discriminate between lung metastatic tumors, primary tumors (fetal and embryonal subtypes), and nontumorous surrounding livers. Our analysis demonstrated that a large cluster of microRNAs and snoRNAs located within the 14q32.2 DLK1-DIO3 region showed a strikingly upregulated expression pattern in HB tumors, especially metastatic tumors, compared to normal liver tissues. This revealed dysregulation of miRNAs similar to that seen in a malignant stem-like subtype of hepatocellular carcinoma associated with poor prognosis. These findings in HB mirror similar findings made in multiple other cancer types. With further analysis this may in future allow stratification of different stages and types of HB tumors based on their miRNA profiles, which could lead to new approaches to diagnosis and treatment in progressive HB patients.
  • Hypermethylation of CSF3R is a novel cisplatin resistance marker and predictor of response to postoperative chemotherapy in hepatoblastoma.
    Sunao Fujiyoshi; Shohei Honda; Masashi Minato; Momoko Ara; Hiromu Suzuki; Eiso Hiyama; Akinobu Taketomi
    Hepatology research : the official journal of the Japan Society of Hepatology, 50, 5, 598, 606, May 2020, [Peer-reviewed], [Lead author], [International Magazine]
    English, Scientific journal, AIM: Most hepatoblastoma patients undergo pre/postoperative cisplatin treatment. Approximately 20% patients are cisplatin resistant, and show poor prognosis and high recurrence rates. However, some cisplatin-sensitive patients show early recurrence. We consider that a small population of cisplatin-resistant cells may remain after preoperative chemotherapy. Previous studies showed a correlation between DNA hypermethylation and hepatoblastoma progression. Here, we examined whether DNA hypermethylation was related to cisplatin resistance and could be a potential indicator for cisplatin as postoperative chemotherapy. METHODS: We extracted DNA from 43 resected hepatoblastoma tumors. Methylation array analyses were performed in 11 samples, including six cisplatin-sensitive and five cisplatin-resistant samples. We also performed cDNA microarray analysis in parental and cisplatin-resistant HuH6 cells. Through comparison of the datasets, we selected the strongest correlated cisplatin-resistant candidate gene. Using bisulfite pyrosequencing, the candidate gene methylation level was assessed in 38 cisplatin-sensitive patients after checking its usefulness as a substitute modality of methylation array. Correlations between the methylation status and clinical data were analyzed. RESULTS: CSF3R was the strongest correlated variable. Bisulfite pyrosequencing analysis also confirmed CSF3R was significantly hypermethylated in cisplatin-resistant patients. Among the 38 cisplatin-sensitive patients, recurrence curves showed that the CSF3R high methylation patients had significantly higher recurrence than CSF3R low methylation patients. The recurrence curve of methylation high patients was similar to that of cisplatin-resistant patients. CONCLUSIONS: Our findings suggested that CSF3R hypermethylation was related to cisplatin resistance in HB patients and could be a predictor of postoperative chemotherapy, and indicate that CSF3R high methylation patients should be treated with non-CDDP regimens.
  • A Case of Penetration of Pseudodiverticulum to Mesosigmoid Hematoma
    Sunao FUJIYOSHI; Masaru NOMURA; Ayami SASAKI; Kouhei UMEMOTO; Jiro OGINO; Kazuyoshi OHMORI
    Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association), 81, 6, 1146, 1150, Japan Surgical Association, 2020, [Peer-reviewed], [Lead author]
    Scientific journal
  • Post-reperfusion hydrogen gas treatment ameliorates ischemia reperfusion injury in rat livers from donors after cardiac death: a preliminary study.
    Takahisa Ishikawa; Shingo Shimada; Moto Fukai; Taichi Kimura; Kouhei Umemoto; Kengo Shibata; Masato Fujiyoshi; Sunao Fujiyoshi; Takahiro Hayasaka; Norio Kawamura; Nozomi Kobayashi; Tsuyoshi Shimamura; Akinobu Taketomi
    Surgery today, 48, 12, 1081, 1088, Dec. 2018, [Domestic magazines]
    English, Scientific journal, BACKGROUND AND PURPOSE: We reported previously that hydrogen gas (H2) reduced hepatic ischemia and reperfusion injury (IRI) after prolonged cold storage (CS) of livers retrieved from heart-beating donors. The present study was designed to assess whether H2 reduced hepatic IRI during donation of a cardiac death (DCD) graft with subsequent CS. METHODS: Rat livers were harvested after 30-min cardiac arrest and stored for 4 h in University of Wisconsin solution. The graft was reperfused with oxygenated buffer, with or without H2 (H2 or NT groups, respectively), at 37° for 90 min on isolated perfused rat liver apparatus. RESULTS: In the NT group, liver enzyme leakage, apoptosis, necrosis, energy depletion, redox status, impaired microcirculation, and bile production were indicative of severe IRI, whereas in the H2 group these impairments were significantly suppressed. The phosphorylation of cytoplasmic MKK4 and JNK were enhanced in the NT group and suppressed in the H2 group. NFkB-p65 and c-Fos in the nucleus were unexpectedly unchanged by IRI regardless of H2 treatment, indicating the absence of inflammation in this model. CONCLUSION: H2 was observed to ameliorate IRI in the DCD liver by maintaining microcirculation, mitochondrial functions, and redox status, as well as suppressing the cytoplasmic MKK4-JNK-mediated cellular death pathway.
  • A Case of Descending Colon Cancer with Inferior Mesenteric Arteriovenous Malformation (AVM) and Retzius Shunt
    Sunao FUJIYOSHI; Yoshito WATANABE; Hayato ECHIZENYA; Hiroshi GONDOH; Kiyoshi KASAI
    Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association), 77, 7, 1720, 1724, Japan Surgical Association, 2016, [Peer-reviewed], [Lead author]
    Scientific journal
  • 当科における脳死肝移植24症例の検討
    藤好 直; 後藤 了一; 青柳 武史; 大浦 哲; 渡辺 正明; 山下 健一郎; 鈴木 友巳; 嶋村 剛; 谷口 雅彦; 古川 博之; 武冨 紹信; 藤堂 省
    日本臨床外科学会雑誌, 74, 12, 3507, 3507, 日本臨床外科学会, Dec. 2013
    Japanese
■ Other Activities and Achievements
■ Affiliated academic society
  • Sep. 2024 - Present
    The Japan Society for Transplantation
  • Aug. 2021 - Present
    Japanese Society of Hepato-Biliary-Pancreatic Surgery
  • Apr. 2016
    日本癌学会
  • Jun. 2015
    日本内視鏡外科学会
  • Aug. 2014
    日本癌治療学会
  • May 2013
    日本消化器外科学会
  • Apr. 2011
    日本外科学会
■ Research Themes